Hologic Overview
- Founded
-
1985
- Status
-
Public
- Employees
-
6,944
- Stock Symbol
-
HOLX
- Investments
-
32
- Share Price
-
$81.37
- (As of Tuesday Closing)
Hologic General Information
Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Contact Information
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
- 250 Campus Drive
- Marlborough, MA 01752
- United States
+1 (508) 000-0000
Hologic Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $81.37 | $82.15 | $59.78 - $82.96 | $20.3B | 247M | 1.63M | $5.18 |
Hologic Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2022 30-Sep-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 |
|---|---|---|---|---|
| EV | 16,576,820 | 16,576,820 | 21,023,604 | 19,790,549 |
| Revenue | 4,862,800 | 4,862,800 | 5,632,300 | 3,776,400 |
| EBITDA | 2,100,500 | 2,100,500 | 2,860,200 | 1,490,100 |
| Net Income | 1,302,000 | 1,302,000 | 1,871,500 | 1,115,200 |
| Total Assets | 9,071,200 | 9,071,200 | 8,919,900 | 7,195,800 |
| Total Debt | 2,921,600 | 2,921,600 | 3,144,600 | 3,147,200 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Hologic Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hologic Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diag
Diagnostic Equipment
Marlborough, MA
6,944
As of 2022
00.000
000000000
00.000
000000
elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
00000000 0000000
New York, NY
000
As of 0000
000.00
000000 - 000
000.00
000000
didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud e
0000000000 000000000
Brea, CA
00000
As of 0000
0.000
0000-00-00
000000&0
Add Comparison
Hologic Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angiodynamics | Corporation | New York, NY | 000 | 000.00 | 000000 - 000 | 000.00 |
| 0000000 0000000 | Corporate Backed or Acquired | Brea, CA | 00000 | 000000&0 | ||
| 0000000 | Formerly VC-backed | Cape Town, South Africa | 0 | 000 | 000000 - 000 | 000 |
| 00000000000 | Corporation | Waltham, MA | 00000 | 00000000 | ||
| 0000 (0000000000 0 | Venture Capital-Backed | New York, NY | 00 | 0000 | 00000000000 | 0000 |
Hologic Patents
Hologic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220361831-A1 | Contrast-enhanced tomosynthesis with a copper filter | Pending | 17-May-2021 | 000000000 | |
| US-20220218294-A1 | Systems and methods for applying force to breasts for imaging | Pending | 13-Jan-2021 | 0000000000 | |
| US-20220164951-A1 | Systems and methods for using ai to identify regions of interest in medical images | Pending | 20-Nov-2020 | 00000000000 | |
| US-20220164586-A1 | Systems and methods for using ai to identify regions of interest in medical images | Pending | 20-Nov-2020 | 00000000000 | |
| EP-3973881-A1 | Light source for an imaging system and methods of the same | Pending | 24-Sep-2020 | A61B6/502 | 0 |
Hologic Executive Team (49)
Hologic Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Amy Wendell | Self | Board Member | 000 0000 |
| Charles Dockendorff | Hologic | Board Member | 000 0000 |
| Christiana Stamoulis | Self | Board Member | 000 0000 |
| Ludwig Hantson Ph.D | Hologic | Board Member | 000 0000 |
| Namal Nawana | Hologic | Board Member | 000 0000 |
Hologic Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Hologic Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hologic Investments & Acquisitions (32)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 29-Nov-2021 | 0000000000 | 00000 | Surgical Devices | 0000000 0 |
| 00000000 | 17-Jun-2021 | 0000000000 | 00000 | Diagnostic Equipment | 0000000 0 |
| 000000000 | 01-Mar-2021 | 0000000000 | 00000 | Biotechnology | 0000000 0 |
| 0000000000000 | 22-Feb-2021 | 0000000000 | 00000 | Laboratory Services (Healthcare) | 00000 000 |
| SOMATEX Medical Technologies | 30-Dec-2020 | Merger/Acquisition | 000.00 | Medical Supplies | 00000000 |
Hologic Subsidiaries (11)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Diagenode | Biotechnology | Seraing, Belgium | 2003 |
| 00000 00000000000 | Diagnostic Equipment | Danbury, CT | 0000 |
| 00000000 | Diagnostic Equipment | Espoo, Finland | 0000 |
| 000000 00000000000 | Therapeutic Devices | Newark, DE | 0000 |
| 000000000000000 | Laboratory Services (Healthcare) | San Diego, CA | 0000 |
Hologic ESG
Risk Overview
Risk Rating
Updated November, 29, 2022
28.24 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,613
Rank
00.00
Percentile
Healthcare
Industry
00 of 635
Rank
00.00
Percentile
Medical Devices
Subindustry
00 of 228
Rank
00.00
Percentile
Hologic Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000 0000000 | 28-Sep-2020 | 000000000000000000 | 00.00 | Completed |
|
| 00000000 (00000000 | 22-Mar-2017 | 000000000000000000 | 00.000 | Completed |
|
| 00000000 0000 | 04-Dec-2013 | 00000 00000 00 | 0000 | Completed |
|
| Sentinelle Medical | 05-Aug-2010 | Merger/Acquisition | 00000 | Completed |